There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
We determine if intravesical bacillus Calmette-Guerin (BCG) reduces the risk of progression
after transurethral resection to stage T2 disease or higher in patients with superficial
(stage Ta, T1 or carcinoma in situ) bladder cancer.